PATENT CLAIM ANALYSIS

Application Number: 15942007
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["530", "387300"]

Abstract:
The present invention relates to methods and compositions for the prevention and treatment of renal damage. The invention provides protein-based renal therapeutic agents for administration to subjects in order to prevent or treat renal degeneration or damage.

Claim (Index 25):
The isolated antibody of claim  4 , wherein the antibody is selected from the group consisting of a monoclonal antibody, a polyclonal antibody, a Fv fragment of an antibody, a Fab fragment of an antibody, a F(ab\u2032)2 fragment of an antibody, a recombinant single chain Fv fragment (scFv), a diabody, a triabody, and a tertrabody.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.39286
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14564979', '13030863', '12459764', '11613658', '11962522']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6903495477034844
- 35 USC 102 Novelty (BERT): 0.5417761968989004
- Combined Prediction Score: 0.6754922126230261
- Mean Citation Score: 337.8414620000001
- Max Citation Score: 383.17712
- Similarity Product: 315.2749522779273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test